Release Date: 19/11/13 08:58 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 243.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%